Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Novartis |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00171756 |
A study to compare the effects of Diovan or Atenolol taken for 12 weeks on platelet function of patients who have mild to moderately severe hypertension
Condition | Intervention | Phase |
---|---|---|
Hypertension |
Drug: valsartan/atenolol |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Double-Blind, Double-Dummy, Multi-Centre, Randomized, Active Controlled, Parallel Group Pilot Trial to Compare the Effects of Valsartan and Atenolol on the Pro-Thrombotic State in Patients With Mild to Moderate Hypertension. |
Estimated Enrollment: | 74 |
Study Start Date: | June 2004 |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
o Uncontrolled hypertension defined as seated blood pressure of either systolic BP >180 mmHg and/or diastolic BP >110mmHg.
Study ID Numbers: | CVAL489AGB09 |
Study First Received: | September 13, 2005 |
Last Updated: | September 21, 2007 |
ClinicalTrials.gov Identifier: | NCT00171756 |
Health Authority: | United Kingdom: National Health Service |
hypertension valsartan |
Vascular Diseases Atenolol Valsartan Hypertension |
Sympatholytics Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Physiological Effects of Drugs Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |
Autonomic Agents Therapeutic Uses Adrenergic beta-Antagonists Cardiovascular Diseases Adrenergic Antagonists Anti-Arrhythmia Agents Peripheral Nervous System Agents |